Chimerix, Inc. (CMRX) Stock Forecast & Price Prediction 2024, 2025, 2030, 2040, and 2050
Stay updated on Chimerix, Inc. (CMRX) stock with short-term forecast for year 2024 and long-term price prediction for 2025 - 2050. Access historical performance, see analyst ratings, and follow the latest Chimerix, Inc. news and developments.
1 Month Prediction
$2.73 [-23.14%]
3 Month Prediction
$2.53 [-28.95%]
6 Month Prediction
$1.75 [-50.90%]
1 Year Prediction
$2.24 [-37.04%]
3 Year Prediction
$2.18 [-38.64%]
5 Year Prediction
$2.17 [-38.89%]
About Chimerix, Inc.
Chimerix, Inc. is a biopharmaceutical company headquartered in Durham, North Carolina, specializing in the development of medicines aimed at improving and extending the lives of patients with serious diseases. The company focuses on oncology and antiviral therapies.
The company's lead product candidate is dordaviprone (ONC201), an imipridone in Phase 3 clinical trials for treating H3 K27M-mutant diffuse glioma, a type of brain tumor. Additionally, ONC201 is in Phase 2 trials for rare neuroendocrine tumors.
Chimerix's pipeline also includes: ONC206: A second-generation imipridone in Phase 1 trials for adult and pediatric central nervous system tumors, ONC212: An imipridone targeting the GPR132 tumor suppressor, and CMX521: A nucleoside analog antiviral candidate for treating SARS-CoV-2.
In 2022, Chimerix entered into a license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for diseases other than orthopoxviruses, including smallpox.
As of December 2024, Chimerix employs approximately 72 individuals.
Chimerix, Inc. (CMRX) Historical Performance
IPO Date
Chimerix, Inc. (NGM:CMRX) went public on 11 April, 2013.
Change
Since inception, CMRX has decreased by 83.47%. In the last 5 years, CMRX has risen from $1.77 to $3.56, a massive 100.85% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $9.81 and a low of $0.88.
52 Week Range
$0.75
$3.8
The current price $3.54 is near the 52-week high, which means that the stock is overbought.
CMRX Stock Price History
Based on CMRX stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the CMRX stock has risen from $1.44 - $4.83 to $3.56 - $3.56, which is up 38.96%. Currently, the stock follows upward trend.
Here, we have calculated stock range of CMRX, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
Year | Stock Price | Avg Price | Change% | Year Change |
---|---|---|---|---|
2020 | $1.44 - $4.83 | $2.75 | 7.35 | 1 Year Change |
2021 | $5.24 - $9.81 | $7.53 | 193.93 | 2 Year Change |
2022 | $1.77 - $5.71 | $3.03 | 18.28 | 3 Year Change |
2023 | $0.94 - $1.77 | $1.21 | -52.77 | 4 Year Change |
2024 | $0.88 - $3.48 | $1.17 | -54.33 | 5 Year Change |
2025 | $3.56 - $3.56 | $3.56 | 38.96 | 6 Year Change |
CMRX Price Performance
6-Month Performance
CMRX stock jumped by 282.26% in the last six months.
1-Year Performance
The stock has trended upwards by 209.13% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 36.97%.
5-Year Performance
In the last 5 years, the stock has gone up by 100.85%.
According to Chimerix, Inc.'s historical data, below graph gives us the exact picture of how the CMRX stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
137.93% ↑
2021
33.13% ↑
2022
71.07% ↓
2023
48.39% ↓
2024
262.50% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Chimerix, Inc. (CMRX) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $26.00 T (Q3)
Revenue for Q3 ending 30th September, 2024 decreased 79.84% compared to Q2 ending 30th June, 2024.
Annual Revenue: $159.00 T (1Y)
Revenue for trailing 12 months decreased 50.93% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone down from $5.37 million to $159.00 thousand, a 97.04% change.
Market Capitalization
Chimerix, Inc. has a market capitalization of $318.51M, which places CMRX in the small-cap category.
Fundamental Analysis
EPS: $-0.26 (Q3), $-0.93 (1Y)
EPS increased 13.04% since last quarter, and decreased 147.21% since last year.
Net Income: $-22.88 M (Q3), $-82.09 M (1Y)
Net Income increased 10.61% since last quarter, and decreased 147.68% since last year.
Free Cash Flow: $-20.53 M (Q3), $-69.18 M (1Y)
Free Cash Flow increased 15.66% since last quarter, and increased 47.38% since last year.
Net Profit Margin: -87996.15% (Q3), -51632.08% (1Y)
Net Profit Margin increased 448.78% since last quarter, and decreased 197.17% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for CMRX stock. These indicators help you understand Chimerix, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for CMRX stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
Technical Indicators | Value |
---|---|
SMA20 | $2.91 |
SMA50 | $1.72 |
SMA200 | $1.12 |
RSI | 68.06 |
Beta | 1.13 |
SMA20 < Current Price
This signals CMRX stock is in short-term bullish momentum.
SMA50 < Current Price
This signals CMRX stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals CMRX stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for CMRX stock is Bullish. Out of all indicators, 4 indicates bullish signals, 2 signals bearish trends and 3 gives neutral trends. The CMRX stock forecast was last updated on 06 January, 2025.
Chimerix, Inc. (CMRX) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $2.16 by the end of 2025, and can reach around $5.12 to $0.46 in 2026. And, the long-term forecast suggests that the stock may further jump to $2.82 - $5.29 in 2028, and $4.91 - $0.12 by 2031. So, the CMRX stock shows a strong downward trend in the next several years.
Short-term CMRX Stock Price Prediction & Forecast
Date | Forecasted Price | Change% |
---|---|---|
2025-02 | $2.73 | -23.21% |
2025-03 | $2.70 | -24.05% |
2025-04 | $2.53 | -28.83% |
2025-05 | $2.43 | -31.65% |
2025-06 | $2.08 | -41.49% |
2025-07 | $1.75 | -50.77% |
2025-08 | $2.07 | -41.77% |
2025-09 | $1.90 | -46.55% |
2025-10 | $1.93 | -45.71% |
2025-11 | $2.06 | -42.05% |
2025-12 | $2.16 | -39.24% |
In 2025, the CMRX stock price is expected to fluctuate between $1.75 and $2.73. According to the monthly forecast, the stock could drop to $2.16 by December 2024. If compared to the CMRX's current price, the stock could lose -39.24% by the end of this year.
Long-term CMRX Stock Price Prediction & Forecast
Year | Year Start | Year Mid | Year End | Change% |
---|---|---|---|---|
2026 | $5.12 | $2.60 | $0.46 | -87.06% |
2027 | $1.79 | $2.93 | $3.47 | -2.39% |
2028 | $2.82 | $0.36 | $5.29 | 48.8% |
2029 | $1.72 | $2.96 | $3.67 | 3.23% |
2030 | $4.13 | $1.99 | $3.86 | 8.58% |
2031 | $4.91 | $0.65 | $0.12 | -96.62% |
2032 | $1.50 | $2.42 | $-1.25 | -135.16% |
2033 | $2.45 | $2.54 | $2.17 | -38.96% |
2034 | $1.63 | $0.39 | $5.38 | 51.34% |
2035 | $1.91 | $1.69 | $3.85 | 8.3% |
2036 | $2.73 | $1.19 | $2.47 | -30.52% |
2037 | $5.52 | $2.81 | $2.23 | -37.27% |
2038 | $2.52 | $2.42 | $1.80 | -49.37% |
2039 | $2.55 | $1.08 | $3.52 | -0.98% |
2040 | $-0.11 | $1.05 | $1.82 | -48.8% |
2041 | $1.20 | $1.66 | $3.42 | -3.8% |
2042 | $5.05 | $1.76 | $4.47 | 25.74% |
2043 | $-0.08 | $3.15 | $2.86 | -19.55% |
2044 | $3.77 | $1.52 | $2.34 | -34.18% |
2045 | $3.20 | $3.02 | $-0.53 | -114.91% |
2046 | $1.85 | $4.98 | $2.40 | -32.49% |
2047 | $0.55 | $1.51 | $3.61 | 1.55% |
2048 | $2.76 | $3.34 | $4.28 | 20.39% |
2049 | $2.67 | $1.84 | $1.33 | -62.59% |
2050 | $1.36 | $-0.13 | $2.03 | -42.9% |
2051 | $3.99 | $1.04 | $-0.65 | -118.28% |
Chimerix, Inc. (CMRX) Stock Price Prediction & Forecast 2025
At the start of 2025, the CMRX stock was at $3.56. Today, it is trading at $3.56, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $2.16 by December 2025 with a -39.24% change.
Chimerix, Inc. (CMRX) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the CMRX stock. During this period, the CMRX's price is forecasted to shift from $5.12 to $3.86, which is -24.61% loss.
In 2026, the stock would possibly open at $5.12, descends to $2.60 by mid-year, and wraps up at $0.46, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $4.13, drop to $1.99 by mid-year, and finish at $3.86, which is 8.54% change from current price.
Chimerix, Inc. (CMRX) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $4.91 to $1.82, which is down -96.53%
In 2031, we can expect CMRX to fluctuate between $0.12 and $4.91, a shift indicating a -96.53% loss by year-end compared to current price. And Until 2040, CMRX can likely vary from $1.82 to $-0.11. By the end of 2040, the stock could record a -48.81% fall from today's stock price.
Chimerix, Inc. (CMRX) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the CMRX stock can see an an upturn from $1.20 to $2.03 in this period. In 2041, the stock can experience a high of $1.66 by mid-year, closing the year at $3.42. This results in a -53.43% decrease from today.
Moving towards the end of 2050, CMRX is projected to open the year at $1.36. The stock may dip to $-0.13 during mid-year and finish the year at $2.03. Compared to the stock's current price, this translates to an overall loss of -42.97% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
CMRX Competitors
Ticker | Company | Market Cap | Price | 1m Change | Forecast |
---|---|---|---|---|---|
RGTI | Rigetti Computing, Inc. | - | $10.04 | -34.21% ▼ | -36.31 ▼ |
MDB | MongoDB, Inc. | - | $246.39 | 0.00% ▼ | $142.32 ▲ |
AMPG | AmpliTech Group, Inc. | - | $4.27 | 0.00% ▼ | $5.3 ▲ |
XPEV | XPeng Inc. | - | $11.71 | 0.00% ▼ | $26.7 ▲ |
AGFY | Agrify Corporation | - | $28.43 | 0.00% ▼ | -39.8 ▼ |
Last updated Jan 06 at 9 PM
CMRX : Buy, Sell Or Hold?
Analyst Ratings
Based on 4 analysts, 1 rated as a strong buy, 3 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for CMRX stock is Buy.Expert Analysis
According to CMRX short-term and long-term forecast, Chimerix, Inc. shares are projected to go down by 42.9%, and reach a value of $2.03 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, CMRX has recorded 9/30 green days, which reflects a 47.368421052631575% positivity rate with a price volatility of 0.40%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that CMRX stock is undervalued. So, Based on CMRX prediction and analysis, it may be the best time to hold CMRX stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "CMRX” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.